Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7Other hematologic neoplasm 4Thoracic 3Myeloid 3Plasma cell 2Lymphoid 2Gastrointestinal 2Dermatologic 2CNS 2Sarcoma 1Other solid neoplasm 1Other 1Head & Neck 1Gynecologic 1

Conditions

Sarcoma 76Gastrointestinal Stromal Tumors 36Dendritic Cell Sarcoma, Interdigitating 22Glioblastoma 20Liposarcoma 19Gliosarcoma 19Neoplasms 18Leiomyosarcoma 16Bone Neoplasms 16Rhabdomyosarcoma 15Neoplasm Metastasis 15Lymphoma, Large B-Cell, Diffuse 15Burkitt Lymphoma 15Central Nervous System Neoplasms 14Sarcoma, Synovial 13Recurrence 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Osteosarcoma 13Hemangiosarcoma 12Fibrosarcoma 12Multiple Myeloma 11Lymphoma, Non-Hodgkin 11Lymphoma, Mantle-Cell 11Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, Follicular 11Lymphoma, B-Cell, Marginal Zone 11Lymphoma 11Leukemia, Myeloid, Chronic-Phase 11Leukemia, Myeloid, Acute 11Leukemia, Myeloid, Accelerated Phase 11

Interventions

Radiotherapy 1Methylphenidate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Depression × Sarcoma × Clear all
NCT00031798 2021-09-09

Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

Wake Forest University Health Sciences

Phase 3 Terminated
CNSSarcoma

Astrocytoma, Brain Neoplasms, Depression, Ependymoma, Fatigue, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡